STATISTICS , PROGRAMMING & DATA MANAGEMENT FOR PHARMACEUTICAL INDUSTRY
CLINICAL DATA MANAGEMENT
We focus on the generation of high-quality, reliable, and statistically sound data from clinical trials. We have extensive experience in all therapeutic areas of data management from Phase I-IV clinical trials. We provide end to end clinical data management solutions from data management plan to database lock
We have also developed an enterprise permissioned blockchain based Clinical Trial Management Solution. Contact us for further information
CDISC SERVICES
Our CDISC services support and accelerate the set-up of CDISC compliant systems and conversions of legacy clinical trial data to the CDISC standards.
By implementing Centreum’s service delivery lifecycle we can support your CDISC conversion requirements from insourcing key activities to outsourcing complete dedicated projects. Our consultants and the virtual team at the client site can aid in the conversion process of legacy data at any stage in any role
BIOSTATISTICS
Centreum has vast experience in the evaluation of clinical data. Our expertise includes the design and conduct of clinical experiments, the method and way in which data is collected, the analysis of data, and the interpretation of results
Our expertise in regulatory submissions and knowledge of Biostatistics helps you to navigate the complexities of study design, randomization, sample size calculation and data visualization etc.
STATISTICAL PROGRAMMING
Clinical trials have complex computational needs. The correct programming approach to deal with such needs involves a robust technology-based trial ecosystem. Strategically designed and programmed technology solutions are the key to successful clinical programming
Centreum offers you a comprehensive range of high quality and cost-effective clinical programming services. We offer accurate data analysis in compliance with regulatory requirements that adjusts to your business needs. We have vast experience in designing, analyzing and reporting clinical studies supported by robust processes and global infrastructure across a broad range of therapeutic areas